A randomized, double-blind, placebo-controlled study to examine the effect of betahistine on plasma lipids in patients treated with simvastatin

Trial Profile

A randomized, double-blind, placebo-controlled study to examine the effect of betahistine on plasma lipids in patients treated with simvastatin

Discontinued
Phase of Trial: Phase II

Latest Information Update: 07 Jun 2007

At a glance

  • Drugs Betahistine (Primary)
  • Indications Lipid metabolism disorders
  • Focus Pharmacodynamics
  • Sponsors OBEcure
  • Most Recent Events

    • 07 Jun 2017 Biomarkers information updated
    • 07 Jun 2007 Status changed from initiated to recruiting.
    • 14 May 2007 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top